Unlearn.ai
AI-powered digital twins and scientific intelligence for faster, smarter clinical trials
Enterprise·Technical·Powered by Unlearn proprietary AI
Key strengths
AI-generated digital twins for patient outcome forecastingEMA-qualified methodology aligned with FDA guidanceIntegrated platform covering trial planning, monitoring, and analysisAutomated literature and regulatory precedent search (Scout)Measurable reductions in control arm size (~33%) and enrollment time (4+ months)
Enterprise pricing
US
Facts verified against unlearn.ai on
Get alerts when Unlearn.ai changes
Free. We'll email you when pricing, the free tier, API access or open-source status changes.
No ratings yet
Documentation & Integration
Unlearn is designed for pharmaceutical and biotech teams managing clinical trial operations and data science workflows. The platform supports:
- Randomized controlled trials (RCTs) and single-arm studies, covering the breadth of common clinical trial designs
- Application at multiple lifecycle stages: pre-trial design, mid-trial augmentation, and post-readout analysis
- Control arm augmentation workflows that reduce required control arm enrollment by approximately 33%
For detailed API references, integration guides, and methodology documentation, consult Unlearn's official developer and clinical documentation resources directly.
Alternatives
See all alternatives